Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiopental sodium + midazolam for hemodynamic response during ETT versus LMA airway placement
IRCT20180416039326N6Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of thiopental and midazolam (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Heart rate, Systolic blood pressure and 3 more. Started Dec 2018; status: completed.
02
Drugs
thiopentalmidazolam
Beyond the preview
Go deeper on IRCT20180416039326N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180416039326N6.